BLK-Max Hospital to administer new drug resistant TB medications free of cost

Officers of National TB Elimination Programme posing with Dr Sandeep Nayar (Senior Director, BLK-Max Super Speciality Hospital).
Officers of National TB Elimination Programme posing with Dr Sandeep Nayar (Senior Director, BLK-Max Super Speciality Hospital).

Excelsior Correspondent

NEW DELHI, July 6: North India’s leading healthcare provider BLK-Max Super Specialty Hospital has become the first private hospital in Delhi and third in India which will administer new drug resistant TB medications free of cost to the patients.
The BLK-Max Super Specialty Hospital has tied-up with the Government to treat Drug Resistant Tuberculosis (DR-TB), with new anti-tubercular medicines, for free of cost. This new drug is available only at Government designated centres and BLK-Max Hospital is the first one to administer this in the Delhi region.
Delhi State TB Control Office recently proposed to partner with BLK- Max Super Speciality Hospital to provide DR-TB treatment services to patients residing in Delhi and seeking care in private sector. The partnership will ensure that the patients seeking care in private sector also receive the diagnostic, treatment, and patient care services as per the standardized PMDT guidelines.
“We are happy to collaborate in the national eradication program for tuberculosis by providing the latest treatments, free of cost under this initiative. Public awareness is important amongst masses, irrespective of their social strata. New drugs available for treatment of TB drugs have a reduced treatment time of six months in comparison to the earlier 12 to 15 months course. Eradication of TB (like Polio) requires sustained efforts from both public and private healthcare systems,” said Dr Sandeep Nayar, Senior Director & HoD, BLK-Max Centre for Chest & Respiratory Diseases, BLK-Max Super Specialty Hospital.
Nayar said it is promising to note that the Government of India has been paying adequate attention on prevention, detection and treatment of the disease.